Sarah M. Hall, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Bloomberg Health Law & Business, in “Trump’s Focus on Medicare Advantage Fraud Poses Enforcement Test,” by Holly Barker. (Read the full version – subscription required.)

Following is an excerpt:

The Trump administration has vowed to ferret out Medicare Advantage fraud, but keeping that promise will mean overcoming challenges that have stymied Justice Department investigations for years.

Big Money

Under the Medicare Advantage program, or Medicare Part C, the Centers for Medicare & Medicaid Services contracts with private plan administrators to provide Medicare coverage.

Those plan administrators receive, for each beneficiary, a fixed payment that’s risk adjusted to approximate the projected cost of the patient’s care.

More than half of the eligible Medicare population opted to enroll in such plans in 2024, according to KFF. Their care accounted for more than $460 billion of total Medicare spending. …

Risk-adjustment fraud occurs when a patient’s diagnoses are misrepresented in order to inflate those payments, a practice that has cost US taxpayers billions, according to CMS and the Office of Inspector General for the Health and Human Services Department.

With those dollar figures at stake and MA payments only set to increase, there are multiple data points indicating a current enhanced federal scrutiny of MA plan administrators, said Sarah Hall, a partner with Epstein Becker & Green PC and a former federal prosecutor.

At his March confirmation hearing, CMS Administrator Dr. Mehmet Oz committed to scrutinizing MA plans. The agency has since announced that it’s enhancing its risk-assessment auditing process.

And senior officials from the DOJ’s civil division have said the agency intends to aggressively enforce the False Claims Act, highlighting MA fraud as a priority.

“The Justice Department under Trump has really gotten behind the FCA, which probably dovetails well with the push to investigate Medicare Advantage fraud,” Hall said.

“Investigators can look at data all day long,” she said. “With the help of whistleblowers, they can unpack complex schemes in a much more expedient way.”

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.